Free Trial
ASX:NVO

Novo Resources (NVO) Stock Price, News & Analysis

Novo Resources logo

About Novo Resources Stock (ASX:NVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Novo Resources Corp., together with its subsidiaries, engages in evaluating, acquiring, exploring, and developing natural resource properties in Canada, Australia, and the United States. The company primarily explores for gold deposits. It holds approximately 7,500 sq km of land in the Pilbara region of Western Australia, as well as interests in various projects located in Victoria, Australia. The company was formerly known as Galliard Resources Corp. and changed its name to Novo Resources Corp. in June 2011. Novo Resources Corp. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Receive NVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Resources and its competitors with MarketBeat's FREE daily newsletter.

NVO Stock News Headlines

Highlights – March Quarter 2025
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
Novo Resources: Highlights – March Quarter 2025
See More Headlines

NVO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Novo Resources investors own include Meta Platforms (META), Kosmos Energy (KOS), Lowe's Companies (LOW), Moderna (MRNA), NVIDIA (NVDA), UiPath (PATH) and Avidity Biosciences (RNA).

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Gold
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:NVO
CIK
N/A
Fax
N/A
Employees
54,400
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-44,850,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.50 million
Price / Cash Flow
2.25
Book Value
A$0.23 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.48
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:NVO) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners